Viewing StudyNCT02637687

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 7:57 AM
Last Modification Date: 2024-10-26 @ 11:54 AM
Study NCT ID: NCT02637687
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-08
First Post: 2015-12-10
Brief Title: A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
Sponsor: Bayer
Organization: Bayer
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Solid Tumors Harboring NTRK Fusion
Keywords:
Name View
ETV6 View
Advanced solid tumors View
Central nervous system CNS tumor View
Extra-cranial tumor View
Infantile fibrosarcoma IFS View
Neurotrophic tyrosine receptor kinase NTRK View
NTRK1 View
NTRK2 View
NTRK3 View
Fusion Positive View
TRK fusion View
TRKA View
TRKB View
TRKC View